ARAY
Price
$1.35
Change
+$0.01 (+0.74%)
Updated
Jul 17, 04:59 PM (EDT)
Capitalization
244.95M
27 days until earnings call
NVST
Price
$19.75
Change
+$0.03 (+0.15%)
Updated
Jul 17 closing price
Capitalization
3.67B
13 days until earnings call
Interact to see
Advertisement

ARAY vs NVST

Header iconARAY vs NVST Comparison
Open Charts ARAY vs NVSTBanner chart's image
Accuray
Price$1.35
Change+$0.01 (+0.74%)
Volume$7.78K
Capitalization244.95M
Envista Holdings
Price$19.75
Change+$0.03 (+0.15%)
Volume$1.19M
Capitalization3.67B
ARAY vs NVST Comparison Chart in %
Loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARAY vs. NVST commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Hold and NVST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (ARAY: $1.36 vs. NVST: $19.75)
Brand notoriety: ARAY and NVST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARAY: 80% vs. NVST: 57%
Market capitalization -- ARAY: $244.95M vs. NVST: $3.67B
ARAY [@Medical Specialties] is valued at $244.95M. NVST’s [@Medical Specialties] market capitalization is $3.67B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileNVST’s FA Score has 0 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARAY and NVST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 4 TA indicator(s) are bullish while NVST’s TA Score has 3 bullish TA indicator(s).

  • ARAY’s TA Score: 4 bullish, 3 bearish.
  • NVST’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARAY is a better buy in the short-term than NVST.

Price Growth

ARAY (@Medical Specialties) experienced а -3.55% price change this week, while NVST (@Medical Specialties) price change was -4.68% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.87%. For the same industry, the average monthly price growth was +3.09%, and the average quarterly price growth was -1.33%.

Reported Earning Dates

ARAY is expected to report earnings on Oct 29, 2025.

NVST is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (-1.87% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVST($3.67B) has a higher market cap than ARAY($245M). NVST YTD gains are higher at: 2.385 vs. ARAY (-31.313). NVST has higher annual earnings (EBITDA): 171M vs. ARAY (5.93M). NVST has more cash in the bank: 940M vs. ARAY (72.8M). ARAY has less debt than NVST: ARAY (202M) vs NVST (1.65B). NVST has higher revenues than ARAY: NVST (2.57B) vs ARAY (447M).
ARAYNVSTARAY / NVST
Capitalization245M3.67B7%
EBITDA5.93M171M3%
Gain YTD-31.3132.385-1,313%
P/E RatioN/A21.74-
Revenue447M2.57B17%
Total Cash72.8M940M8%
Total Debt202M1.65B12%
FUNDAMENTALS RATINGS
ARAY vs NVST: Fundamental Ratings
ARAY
NVST
OUTLOOK RATING
1..100
8182
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8896
PRICE GROWTH RATING
1..100
6346
P/E GROWTH RATING
1..100
4286
SEASONALITY SCORE
1..100
3950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (63) in the null industry is in the same range as ARAY (86) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ARAY’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as ARAY (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's SMR Rating (88) in the Medical Specialties industry is in the same range as NVST (96) in the null industry. This means that ARAY’s stock grew similarly to NVST’s over the last 12 months.

NVST's Price Growth Rating (46) in the null industry is in the same range as ARAY (63) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's P/E Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for NVST (86) in the null industry. This means that ARAY’s stock grew somewhat faster than NVST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYNVST
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
70%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 8 days ago
67%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 2 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETCGX46.15N/A
N/A
Eventide Gilead C
HAVGX25.44N/A
N/A
Haverford Quality Growth Stock
VWNEX72.37N/A
N/A
Vanguard Windsor™ Admiral™
SECUX37.54N/A
N/A
NAA Mid Growth A
BIVIX16.83N/A
N/A
Invenomic Institutional

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with ALGN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+0.74%
ALGN - ARAY
46%
Loosely correlated
+1.07%
ILMN - ARAY
45%
Loosely correlated
+1.00%
KIDS - ARAY
44%
Loosely correlated
+0.40%
A - ARAY
42%
Loosely correlated
+2.58%
NVST - ARAY
41%
Loosely correlated
+0.15%
More

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with ALGN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
+0.15%
ALGN - NVST
65%
Loosely correlated
+1.07%
A - NVST
56%
Loosely correlated
+2.58%
MTD - NVST
55%
Loosely correlated
+1.81%
XRAY - NVST
54%
Loosely correlated
-0.19%
RVTY - NVST
53%
Loosely correlated
+0.72%
More